Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study.

Jakimovski D, Weinstock-Guttman B, Gandhi S, Guan Y, Hagemeier J, Ramasamy DP, Fuchs TA, Browne RW, Bergsland N, Dwyer MG, Ramanathan M, Zivadinov R.

J Neurol. 2019 Feb 13. doi: 10.1007/s00415-019-09208-0. [Epub ahead of print]

PMID:
30758665
2.

Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine.

Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Paunkoski I, Ramasamy DP, Silva D, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R.

AJNR Am J Neuroradiol. 2018 Dec;39(12):2237-2242. doi: 10.3174/ajnr.A5876. Epub 2018 Nov 22.

PMID:
30467212
3.

Assessment of mesoscopic properties of deep gray matter iron through a model-based simultaneous analysis of magnetic susceptibility and R2* - A pilot study in patients with multiple sclerosis and normal controls.

Taege Y, Hagemeier J, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R, Schweser F.

Neuroimage. 2019 Feb 1;186:308-320. doi: 10.1016/j.neuroimage.2018.11.011. Epub 2018 Nov 14.

PMID:
30445148
4.

Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage.

Jakimovski D, Weinstock-Guttman B, Hagemeier J, Vaughn CB, Kavak KS, Gandhi S, Bennett SE, Fuchs TA, Bergsland N, Dwyer MG, Benedict RHB, Zivadinov R.

J Neurol Sci. 2018 Oct 15;393:128-134. doi: 10.1016/j.jns.2018.08.020. Epub 2018 Aug 23.

PMID:
30165291
5.

Abnormal venous postural control: multiple sclerosis-specific change related to gray matter pathology or age-related neurodegenerative phenomena?

Jakimovski D, Topolski M, Kimura K, Marr K, Gandhi S, Ramasamy DP, Bergsland N, Hagemeier J, Weinstock-Guttman B, Zivadinov R.

Clin Auton Res. 2018 Aug 17. doi: 10.1007/s10286-018-0555-6. [Epub ahead of print]

PMID:
30120624
6.

Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study.

Jakimovski D, Gandhi S, Paunkoski I, Bergsland N, Hagemeier J, Ramasamy DP, Hojnacki D, Kolb C, Benedict RHB, Weinstock-Guttman B, Zivadinov R.

Eur J Neurol. 2019 Jan;26(1):87-e8. doi: 10.1111/ene.13769. Epub 2018 Sep 3.

PMID:
30103277
7.

Multimodal Imaging of Retired Professional Contact Sport Athletes Does Not Provide Evidence of Structural and Functional Brain Damage.

Zivadinov R, Polak P, Schweser F, Bergsland N, Hagemeier J, Dwyer MG, Ramasamy DP, Baker JG, Leddy JJ, Willer BS.

J Head Trauma Rehabil. 2018 Sep/Oct;33(5):E24-E32. doi: 10.1097/HTR.0000000000000422.

PMID:
30080799
8.

Five-Year Longitudinal Study of Neck Vessel Cross-Sectional Area in Multiple Sclerosis.

Pelizzari L, Jakimovski D, Laganà MM, Bergsland N, Hagemeier J, Baselli G, Weinstock-Guttman B, Zivadinov R.

AJNR Am J Neuroradiol. 2018 Sep;39(9):1703-1709. doi: 10.3174/ajnr.A5738. Epub 2018 Jul 26.

PMID:
30049718
9.

Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis.

Zivadinov R, Tavazzi E, Bergsland N, Hagemeier J, Lin F, Dwyer MG, Carl E, Kolb C, Hojnacki D, Ramasamy D, Durfee J, Weinstock-Guttman B, Schweser F.

Radiology. 2018 Nov;289(2):487-496. doi: 10.1148/radiol.2018180136. Epub 2018 Jul 17.

PMID:
30015589
10.

Altered nuclei-specific thalamic functional connectivity patterns in multiple sclerosis and their associations with fatigue and cognition.

Lin F, Zivadinov R, Hagemeier J, Weinstock-Guttman B, Vaughn C, Gandhi S, Jakimovski D, Hulst HE, Benedict RH, Bergsland N, Fuchs T, Dwyer MG.

Mult Scler. 2018 Jul 1:1352458518788218. doi: 10.1177/1352458518788218. [Epub ahead of print]

PMID:
30004291
11.

The Effect of Glatiramer Acetate on Retinal Nerve Fiber Layer Thickness in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.

Zivadinov R, Tavazzi E, Hagemeier J, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B.

CNS Drugs. 2018 Aug;32(8):763-770. doi: 10.1007/s40263-018-0521-9.

PMID:
29767815
12.

Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.

Zivadinov R, Bergsland N, Hagemeier J, Carl E, Kolb H, Hojnacki D, Weinstock-Guttman B.

J Neurol Sci. 2018 May 15;388:175-181. doi: 10.1016/j.jns.2018.03.028. Epub 2018 Mar 17.

PMID:
29627017
13.

Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.

Zivadinov R, Bergsland N, Hagemeier J, Tavazzi E, Ramasamy DP, Durfee J, Cherneva M, Carl E, Carl J, Kolb C, Hojnacki D, Weinstock-Guttman B.

J Neurol Sci. 2018 Apr 15;387:152-156. doi: 10.1016/j.jns.2018.02.023. Epub 2018 Feb 10.

PMID:
29571854
14.

Establishing pathological cut-offs for lateral ventricular volume expansion rates.

Dwyer MG, Hagemeier J, Bergsland N, Horakova D, Korn JR, Khan N, Uher T, Medin J, Silva D, Vaneckova M, Havrdova EK, Zivadinov R.

Neuroimage Clin. 2018 Feb 7;18:494-501. doi: 10.1016/j.nicl.2018.02.009. eCollection 2018.

15.

Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis.

Zivadinov R, Ramasamy DP, Hagemeier J, Kolb C, Bergsland N, Schweser F, Dwyer MG, Weinstock-Guttman B, Hojnacki D.

AJNR Am J Neuroradiol. 2018 Apr;39(4):642-647. doi: 10.3174/ajnr.A5541. Epub 2018 Feb 8.

PMID:
29439125
16.

Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease.

Guttuso T Jr, Bergsland N, Hagemeier J, Lichter DG, Pasternak O, Zivadinov R.

AJNR Am J Neuroradiol. 2018 Feb 1. doi: 10.3174/ajnr.A5545. [Epub ahead of print]

PMID:
29419398
17.

Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study.

Zivadinov R, Hagemeier J, Bergsland N, Tavazzi E, Weinstock-Guttman B.

Eur J Neurol. 2018 Mar;25(3):584-e36. doi: 10.1111/ene.13562.

PMID:
29316038
18.

Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis.

Belov P, Jakimovski D, Krawiecki J, Magnano C, Hagemeier J, Pelizzari L, Weinstock-Guttman B, Zivadinov R.

AJNR Am J Neuroradiol. 2018 Jan;39(1):123-130. doi: 10.3174/ajnr.A5469. Epub 2017 Dec 7.

19.

Neck Vessel Cross-Sectional Area Measured with MRI: Scan-Rescan Reproducibility for Longitudinal Evaluations.

Pelizzari L, Laganà MM, Jakimovski D, Bergsland N, Hagemeier J, Baselli G, Zivadinov R.

J Neuroimaging. 2018 Jan;28(1):48-56. doi: 10.1111/jon.12488. Epub 2017 Dec 4.

20.

Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals.

Hagemeier J, Ramanathan M, Schweser F, Dwyer MG, Lin F, Bergsland N, Weinstock-Guttman B, Zivadinov R.

Neuroimage Clin. 2017 Nov 8;17:530-540. doi: 10.1016/j.nicl.2017.11.003. eCollection 2018.

21.

Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality.

Schweser F, Raffaini Duarte Martins AL, Hagemeier J, Lin F, Hanspach J, Weinstock-Guttman B, Hametner S, Bergsland N, Dwyer MG, Zivadinov R.

Neuroimage. 2018 Feb 15;167:438-452. doi: 10.1016/j.neuroimage.2017.10.063. Epub 2017 Oct 31.

22.

Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis.

Modica CM, Schweser F, Sudyn ML, Bertolino N, Preda M, Polak P, Siebert DM, Krawiecki JC, Sveinsson M, Hagemeier J, Dwyer MG, Pol S, Zivadinov R.

PLoS One. 2017 Aug 10;12(8):e0182729. doi: 10.1371/journal.pone.0182729. eCollection 2017.

23.

Centralized and Local Color Doppler Ultrasound Reading Agreement for Diagnosis of the Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis.

Caprio MG, Marr K, Gandhi S, Jakimovski D, Hagemeier J, Weinstock-Guttman B, Zivadinov R, Mancini M.

Curr Neurovasc Res. 2017;14(3):266-273. doi: 10.2174/1567202614666170718095203.

24.

Olfactory identification deficit predicts white matter tract impairment in Alzheimer's disease.

Woodward MR, Dwyer MG, Bergsland N, Hagemeier J, Zivadinov R, Benedict RH, Szigeti K.

Psychiatry Res Neuroimaging. 2017 Aug 30;266:90-95. doi: 10.1016/j.pscychresns.2017.06.004. Epub 2017 Jun 9.

25.

Changes of deep gray matter magnetic susceptibility over 2 years in multiple sclerosis and healthy control brain.

Hagemeier J, Zivadinov R, Dwyer MG, Polak P, Bergsland N, Weinstock-Guttman B, Zalis J, Deistung A, Reichenbach JR, Schweser F.

Neuroimage Clin. 2017 Apr 13;18:1007-1016. doi: 10.1016/j.nicl.2017.04.008. eCollection 2018.

26.

Methods for the computation of templates from quantitative magnetic susceptibility maps (QSM): Toward improved atlas- and voxel-based analyses (VBA).

Hanspach J, Dwyer MG, Bergsland NP, Feng X, Hagemeier J, Bertolino N, Polak P, Reichenbach JR, Zivadinov R, Schweser F.

J Magn Reson Imaging. 2017 Nov;46(5):1474-1484. doi: 10.1002/jmri.25671. Epub 2017 Mar 6.

27.

An improved FSL-FIRST pipeline for subcortical gray matter segmentation to study abnormal brain anatomy using quantitative susceptibility mapping (QSM).

Feng X, Deistung A, Dwyer MG, Hagemeier J, Polak P, Lebenberg J, Frouin F, Zivadinov R, Reichenbach JR, Schweser F.

Magn Reson Imaging. 2017 Jun;39:110-122. doi: 10.1016/j.mri.2017.02.002. Epub 2017 Feb 7.

28.

Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study.

Zivadinov R, Ramasamy DP, Vaneckova M, Gandhi S, Chandra A, Hagemeier J, Bergsland N, Polak P, Benedict RH, Hojnacki D, Weinstock-Guttman B.

Mult Scler. 2017 Sep;23(10):1336-1345. doi: 10.1177/1352458516678083. Epub 2016 Nov 4.

PMID:
27811339
29.

Interdependence of oxysterols with cholesterol profiles in multiple sclerosis.

Mukhopadhyay S, Fellows K, Browne RW, Khare P, Krishnan Radhakrishnan S, Hagemeier J, Weinstock-Guttman B, Zivadinov R, Ramanathan M.

Mult Scler. 2017 May;23(6):792-801. doi: 10.1177/1352458516666187. Epub 2016 Sep 28.

30.

Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy.

Hagemeier J, Woodward MR, Rafique UA, Amrutkar CV, Bergsland N, Dwyer MG, Benedict R, Zivadinov R, Szigeti K.

Psychiatry Res Neuroimaging. 2016 Sep 30;255:87-93. doi: 10.1016/j.pscychresns.2016.08.003. Epub 2016 Aug 15.

PMID:
27567325
31.

Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study.

Zivadinov R, Ramasamy DP, Benedict RR, Polak P, Hagemeier J, Magnano C, Dwyer MG, Bergsland N, Bertolino N, Weinstock-Guttman B, Kolb C, Hojnacki D, Utriainen D, Haacke EM, Schweser F.

Radiology. 2016 Dec;281(3):884-895. Epub 2016 Jun 16.

PMID:
27308776
32.

Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.

Beggs CB, Magnano C, Belov P, Krawiecki J, Ramasamy DP, Hagemeier J, Zivadinov R.

PLoS One. 2016 May 2;11(5):e0153960. doi: 10.1371/journal.pone.0153960. eCollection 2016.

33.

Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years.

Zivadinov R, Hojnacki D, Bergsland N, Kennedy C, Hagemeier J, Melia R, Ramasamy DP, Durfee J, Carl E, Dwyer MG, Weinstock-Guttman B.

Eur J Neurol. 2016 Jun;23(6):1101-9. doi: 10.1111/ene.12992. Epub 2016 Mar 21.

PMID:
26998905
34.

Age-related brain atrophy may be mitigated by internal jugular vein enlargement in male individuals without neurologic disease.

Belov P, Magnano C, Krawiecki J, Hagemeier J, Bergsland N, Beggs C, Zivadinov R.

Phlebology. 2017 Mar;32(2):125-134. doi: 10.1177/0268355516633610. Epub 2016 Jul 9.

PMID:
26911619
35.

Internal Jugular Vein Cross-Sectional Area Enlargement Is Associated with Aging in Healthy Individuals.

Magnano C, Belov P, Krawiecki J, Hagemeier J, Beggs C, Zivadinov R.

PLoS One. 2016 Feb 19;11(2):e0149532. doi: 10.1371/journal.pone.0149532. eCollection 2016.

36.

A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.

Zivadinov R, Uher T, Hagemeier J, Vaneckova M, Ramasamy DP, Tyblova M, Bergsland N, Seidl Z, Dwyer MG, Krasensky J, Havrdova E, Horakova D.

Mult Scler. 2016 Nov;22(13):1709-1718. Epub 2016 Feb 16.

PMID:
26883943
37.

Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.

Weinstock-Guttman B, Hagemeier J, Kavak KS, Saini V, Patrick K, Ramasamy DP, Nadeem M, Carl E, Hojnacki D, Zivadinov R.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):937-43. doi: 10.1136/jnnp-2015-312221. Epub 2016 Jan 18.

PMID:
26780938
38.

Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS.

Zivadinov R, Cerza N, Hagemeier J, Carl E, Badgett D, Ramasamy DP, Weinstock-Guttman B, Ramanathan M.

Neurol Neuroimmunol Neuroinflamm. 2016 Jan 7;3(1):e190. doi: 10.1212/NXI.0000000000000190. eCollection 2016 Feb.

39.

Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients.

Graziano E, Hagemeier J, Weinstock-Guttman B, Ramasamy DP, Zivadinov R.

Neuroimage Clin. 2015 Aug 1;9:110-6. doi: 10.1016/j.nicl.2015.07.013. eCollection 2015.

40.

Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome.

Varosanec M, Uher T, Horakova D, Hagemeier J, Bergsland N, Tyblova M, Seidl Z, Vaneckova M, Krasensky J, Dwyer MG, Havrdova E, Zivadinov R.

AJNR Am J Neuroradiol. 2015 Aug;36(8):1457-64. doi: 10.3174/ajnr.A4330. Epub 2015 Jun 25.

41.

Dirty-Appearing White Matter in the Brain is Associated with Altered Cerebrospinal Fluid Pulsatility and Hypertension in Individuals without Neurologic Disease.

Beggs CB, Magnano C, Shepherd SJ, Belov P, Ramasamy DP, Hagemeier J, Zivadinov R.

J Neuroimaging. 2016 Jan-Feb;26(1):136-43. doi: 10.1111/jon.12249. Epub 2015 Apr 20.

PMID:
25893376
42.

Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis.

Kappus N, Weinstock-Guttman B, Hagemeier J, Kennedy C, Melia R, Carl E, Ramasamy DP, Cherneva M, Durfee J, Bergsland N, Dwyer MG, Kolb C, Hojnacki D, Ramanathan M, Zivadinov R.

J Neurol Neurosurg Psychiatry. 2016 Feb;87(2):181-7. doi: 10.1136/jnnp-2014-310051. Epub 2015 Feb 26.

PMID:
25722366
43.

Effects of diet on brain iron levels among healthy individuals: an MRI pilot study.

Hagemeier J, Tong O, Dwyer MG, Schweser F, Ramanathan M, Zivadinov R.

Neurobiol Aging. 2015 Apr;36(4):1678-1685. doi: 10.1016/j.neurobiolaging.2015.01.010. Epub 2015 Jan 17.

PMID:
25680267
44.

Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset.

Kavak KS, Teter BE, Hagemeier J, Zakalik K, Weinstock-Guttman B; New York State Multiple Sclerosis Consortium.

Mult Scler. 2015 Jun;21(7):858-65. doi: 10.1177/1352458514555787. Epub 2014 Nov 12.

PMID:
25392327
45.

Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study.

Browne RW, Weinstock-Guttman B, Zivadinov R, Horakova D, Bodziak ML, Tamaño-Blanco M, Badgett D, Tyblova M, Vaneckova M, Seidl Z, Krasensky J, Bergsland N, Ramasamy DP, Hagemeier J, Qu J, Havrdova E, Ramanathan M.

J Steroid Biochem Mol Biol. 2014 Sep;143:424-33. doi: 10.1016/j.jsbmb.2014.06.007. Epub 2014 Jun 17.

PMID:
24950029
46.

Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: results from the multi-center set study.

Zivadinov R, Chin J, Horakova D, Bergsland N, Weinstock-Guttman B, Tamaño-Blanco M, Badgett D, Hagemeier J, Tyblova M, Carl E, Krasensky J, Vaneckova M, Seidl Z, Dwyer MG, Havrdova E, Ramanathan M.

J Neuroimmunol. 2014 Aug 15;273(1-2):58-64. doi: 10.1016/j.jneuroim.2014.04.012. Epub 2014 Apr 30.

PMID:
24907902
47.

Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders.

Hagemeier J, Heininen-Brown M, Gabelic T, Guttuso T Jr, Silvestri N, Lichter D, Fugoso LE, Bergsland N, Carl E, Geurts JJ, Weinstock-Guttman B, Zivadinov R.

AJNR Am J Neuroradiol. 2014 Oct;35(10):1916-23. doi: 10.3174/ajnr.A3969. Epub 2014 May 29.

48.

Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients.

Zivadinov R, Bergsland N, Cappellani R, Hagemeier J, Melia R, Carl E, Dwyer MG, Lincoff N, Weinstock-Guttman B, Ramanathan M.

Eur J Neurol. 2014 Aug;21(8):1137-e61. doi: 10.1111/ene.12449. Epub 2014 Apr 30.

PMID:
24779967
49.

Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.

Jacobsen C, Hagemeier J, Myhr KM, Nyland H, Lode K, Bergsland N, Ramasamy DP, Dalaker TO, Larsen JP, Farbu E, Zivadinov R.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1109-15. doi: 10.1136/jnnp-2013-306906. Epub 2014 Feb 19.

PMID:
24554101
50.

Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes.

Browne RW, Weinstock-Guttman B, Horakova D, Zivadinov R, Bodziak ML, Tamaño-Blanco M, Badgett D, Tyblova M, Vaneckova M, Seidl Z, Krasensky J, Bergsland N, Ramasamy DP, Hagemeier J, Havrdova E, Ramanathan M.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):859-64. doi: 10.1136/jnnp-2013-307106. Epub 2014 Jan 27.

PMID:
24470599

Supplemental Content

Loading ...
Support Center